Phase II study of trastuzumab in combination with S-1 and cisplatin in the first-line treatment of human epidermal growth factor receptor HER2-positive advanced gastric cancer
Crossref DOI link: https://doi.org/10.1007/s00280-015-2811-y
Published Online: 2015-06-24
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chua, Clarinda
Tan, Iain Beehuat
Yamada, Yasuhide
Rha, Sun Young
Yong, Wei Peng
Ong, Whee Sze
Tham, Chee Kian
Ng, Matthew
Tai, David W. M.
Iwasa, Satoru
Lim, Hwee Yong
Choo, Su-Pin
Text and Data Mining valid from 2015-06-24